Wednesday, June 29, 2022
  • 🔒Privacy Policy
  • © Copyright
The Voiceof London
  • Latest news
  • Foreign affairs
  • UK
  • USA
  • Russia
  • Health
  • Fashion
  • Food
  • Contact us
  • Latest news
  • Foreign affairs
  • UK
  • USA
  • Russia
  • Health
  • Fashion
  • Food
  • Contact us
No Result
View All Result
The Voiceof London
No Result
View All Result
Home Health
Save the Children UK’s new Chief Executive vows to focus on impact

Chief.AI and Medicines Discovery Catapult harness the power of AI for new pay as you go drug discovery platform

The Voiceof London by The Voiceof London
July 20, 2021
in Health
0

Chief.AI, in partnership with Medicines Discovery Catapult (MDC), has launched the first no-code, pay as you go, AI platform for drug discovery – offering greater access to AI and data in the areas of drug discovery, diagnostics and clinical trials.

The project, supported by an Innovate UK grant, saw Chief.AI and MDC collaborate on the development of the platform – with MDC developing the models, and Chief.AI the orchestration engine.

The cloud-based system simplifies the use of AI models for SMEs by providing access to valuable information, skills, resources, and expertise at the click of a button. It also provides production infrastructure and analytics for models; harnessing the power of AI in drug discovery like never before.

Chief.AI is the first no-code service of its type in the bioinformatics arena, meaning that SMEs can build applications quickly and without the requirement of substantial and expensive internal IT capabilities.

Development times can also be hugely reduced, any required changes –  – whether due to altered circumstances or  increased functionality – can be done so swiftly and at little cost.

The ability to utilise AI in this way is a huge advantage in an industry where the potential cost of failure is huge – 90% of potential drug candidates fail, often to the cost of hundreds of millions of pounds.

In drug discovery, AI can be utilised to resolve issues that have previously existed in the industry. It could, for example, be used to analyse and predict the behaviour of molecules in the human body much earlier than traditional methods, which financially could save billions in research and development.

Waqar Ali, Founder of Chief.AI said: “As an orchestrator of AI, we are delighted to be able to make access to AI easier and more effective for healthcare providers around the world. Artificial intelligence will prove to be a great force multiplier for data intensive applications such as drug discovery and diagnostics, and with the help of the Medicines Discovery Catapult, Chief.AI is strategically poised to enable businesses around the world to connect to AI and reap these efficiencies seamlessly.”

Prof. John P. Overington, Chief Informatics Officer, Medicines Discovery Catapult, said: “This is a very exciting time for drug discovery. The development and utilisation of AI has been something that the industry has needed to propel that next step forward, and with Chief.AI it is now possible. AI is going to be something that will permeate across all aspects of society and business in the years to come and it is wonderful that we are able to offer this platform to UK SMEs, providing them with information and expertise which otherwise would have been inaccessible.”

Find out more about Chief.AI.

Previous Post

Britons shocked by new migrant crisis as 430 arrive on English shores in 1 day, a new record — RT UK News

Next Post

Medicines Discovery Catapult welcomes new scientific and people leaders

Related Posts

Improving rural care and health equity with telemedicine
Health

Improving rural care and health equity with telemedicine

June 28, 2022
Meta Platforms sued for alleged unlawful collection of patient data
Health

Meta Platforms sued for alleged unlawful collection of patient data

June 28, 2022
Healthcare data breach roundup: Atrium, Kaiser, UNC and more
Health

Healthcare data breach roundup: Atrium, Kaiser, UNC and more

June 28, 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Voiceof London

 

Browse UK newspapers news, research and analysis from The Voiceof London

📧 Please feel free to contact us by an email if you need more information

  • 🔒Privacy Policy
  • © Copyright
No Result
View All Result
  • Latest news
  • Foreign affairs
  • UK
  • USA
  • Russia
  • Health
  • Fashion
  • Food
  • Contact us

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT